Publication of Preclinical Results Demonstrates That masitinib Can Act as a Potentiator of Chemotherapies Outlet: 21 Feb, 2011 This study, conducted by Dr Douglas Thamm (VMD, Diplomate ACVIM Oncology; Colorado State University) and colleagues, investigated the ability of masitinib to sensitize different canine cancer cell lines to various chemotherapeutic agents. link
